Literature DB >> 20636792

Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers.

Matthew Brown1, Karim Sillah, Ewen A Griffiths, Ric Swindell, Catherine M West, Richard D Page, Ian M Welch, Susan A Pritchard.   

Abstract

AIMS: Tumour budding and host inflammatory response are parameters easily assessed histologically that have prognostic significance in many cancers. There have been few studies examining these parameters in oesophageal or gastro-oesophageal cancers. This study aims to address that deficiency. METHODS AND
RESULTS: A two-centre, retrospective study was carried out on 356 patients. Tumour budding and host inflammatory response at the invasive front were assessed histologically. Statistical analysis was performed to determine the prognostic significance of these factors. The median number of tumour buds was four (range 0-50) with 172 of 356 cases having five or more buds at the invasive front. The presence of five or more buds was associated with a poor prognosis on univariate analysis (P = 0.0001), as was a sparse or moderate host inflammatory response (P = 0.001). Tumour budding retained prognostic significance when tumours were separated into adenocarcinomas (n = 287) and squamous cell carcinomas (n = 69), but host inflammatory response was a significant prognostic factor only for adenocarcinomas. On multivariate analysis the presence of five or more buds retained significance (P = 0.002).
CONCLUSIONS: Tumour budding and host inflammatory response are important prognostic factors in patients with oesophageal/gastro-oesophageal cancer and can be used to identify high-risk patients who would benefit from closer follow-up and adjuvant therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20636792     DOI: 10.1111/j.1365-2559.2010.03559.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  28 in total

1.  Analysis of Endoscopy Findings to Identify Early Gastric Cancers with Tumor Budding: A Retrospective Study.

Authors:  Lanqing Cao; Zhaoyong Wang; Liwei Duan; Lijuan Wei
Journal:  J Gastrointest Surg       Date:  2020-11-09       Impact factor: 3.452

2.  Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.

Authors:  Cheng Wang; Hongzhang Huang; Zhiquan Huang; Anxun Wang; Xiaohua Chen; Lei Huang; Xiaofeng Zhou; Xiqiang Liu
Journal:  J Oral Pathol Med       Date:  2011-04-12       Impact factor: 4.253

3.  Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?

Authors:  Fabio Grizzi; Giuseppe Celesti; Gianluca Basso; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 4.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

5.  Tumor budding and dedifferentiation in gallbladder carcinoma: potential for the prognostic factors in T2 lesions.

Authors:  Keita Kai; Naohiko Kohya; Kenji Kitahara; Masanori Masuda; Atsushi Miyoshi; Takao Ide; Osamu Tokunaga; Kohji Miyazaki; Hirokazu Noshiro
Journal:  Virchows Arch       Date:  2011-07-22       Impact factor: 4.064

6.  The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer.

Authors:  David T Pointer; Jordan A McDonald; Samer A Naffouje; Rutika Mehta; Jason B Fleming; Jacques P Fontaine; Gregory Y Lauwers; Jessica M Frakes; Sarah E Hoffe; Jose M Pimiento
Journal:  J Surg Oncol       Date:  2022-05-16       Impact factor: 2.885

Review 7.  Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review.

Authors:  M Priyanthi Kumarasinghe; Michael J Bourke; Ian Brown; Peter V Draganov; Duncan McLeod; Catherine Streutker; Spiro Raftopoulos; Tetsuo Ushiku; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2020-01-06       Impact factor: 7.842

8.  Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.

Authors:  Martin Wartenberg; Inti Zlobec; Aurel Perren; Viktor Hendrik Koelzer; Beat Gloor; Alessandro Lugli; Eva Karamitopoulou
Journal:  Oncotarget       Date:  2015-02-28

9.  Expression of SLP-2 was associated with invasion of esophageal squamous cell carcinoma.

Authors:  Wenfeng Cao; Bin Zhang; Fang Ding; Weiran Zhang; Baocun Sun; Zhihua Liu
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

Review 10.  Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?

Authors:  Eva Karamitopoulou
Journal:  Front Oncol       Date:  2013-09-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.